Movicol® Unidose (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Polyethylene glycol 3350 is a large, non‑absorbed polymer that retains water in the intestinal lumen by creating an osmotic gradient. The added electrolytes help maintain fluid balance, softening stool and promoting natural peristaltic movements without systemic absorption.

The dose of Movicol® Unidose is individualized by the prescribing healthcare professional based on the patient’s condition, age, and response. Typical regimens follow clinical guidelines, but the exact amount and frequency should always be confirmed with the prescriber.

Safety data for Movicol® Unidose in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any possible risk, and the decision must be made by a qualified healthcare provider after evaluating the individual situation.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives such as senna, Movicol® Unidose works by osmotic water retention rather than stimulating intestinal muscles, often resulting in a gentler, more predictable effect. Unlike lactulose, it contains electrolytes that help maintain fluid balance, making it suitable for bowel preparation as well as constipation relief.

Store the sachets at ambient temperature, below 25 °C, in their original packaging. Protect them from moisture and direct sunlight to preserve product integrity. No refrigeration is required.

Each single‑dose sachet is mixed with a specified amount of water (usually 125 ml to 250 ml) as instructed on the label, stirred until fully dissolved, and then consumed promptly. The solution should be taken on an empty stomach unless otherwise directed by a healthcare professional.

The most serious risks include severe electrolyte disturbances such as hyponatraemia or hypokalaemia, significant dehydration, and rare allergic reactions that may present as rash, swelling or anaphylaxis. Patients should seek immediate medical attention if they experience any of these symptoms.

Movicol® Unidose should be avoided in individuals with known hypersensitivity to polyethylene glycol or any of its electrolyte components, in patients with severe renal impairment, and in those with intestinal obstruction or perforation. A healthcare professional should assess suitability before initiation.